Results 71 to 80 of about 5,549 (198)
Canadian Journal of Infectious Diseases and Medical Microbiology, 2018 Evaluation of the in vitro interaction of doripenem and amikacin against Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae was done by classifying them into four groups: doripenem and amikacin sensitive (DOR-S/AMK-S), doripenem ...
Tonny Loho +5 more
doaj +1 more source
Canadian Journal of Infectious Diseases and Medical Microbiology, Volume 2026, Issue 1, 2026.Background The global spread of carbapenemase‐producing Enterobacterales (CPE) has emerged as a significant public health challenge. However, epidemiological studies on CPE infections in Latin America remain scarce. This study aims to characterize bloodstream infections (BSIs) caused by CPE at a tertiary hospital over a 6‐year period and analyze the ...
Juan David Cáceres-González +6 more
wiley +1 more source
A Novel Carbapenem; Doripenem Monohydrate
, 2013 Karbapenem grubunun 2007 yılında FDA (Food and Drug Administration) onayı alan en son üyesi doripenem monohidrat, 1 beta metil grubu içeren sentetik bir analogtur. Doripenem, di er karbapenemler gibi konsantrasyona de il, zamana ba ımlı bakterisidal etki
Dikici, Nebahat, Sümer, Şua
core
Efficacy of doripenem against Escherichia coli and Klebsiella pneumoniae in experimental meningitis [PDF]
, 2017 Objectives In this study the efficacy of doripenem, a new broad-spectrum carbapenem, was tested against an Escherichia coli strain and a Klebsiella pneumoniae strain in an experimental animal model. The comparator was cefepime monotherapy.
Egerman, Ueli +5 more
core
Comparative activity of carbapenem testing (the COMPACT study) in Turkey
BMC Infectious Diseases, 2012 Background Recent evidence indicates that Gram-negative bacterial pathogens, the most common of which are Pseudomonas spp., Enterobacteriaceae, and Acinetobacter baumannii, are frequent causes of hospital-acquired infections.
Leblebicioglu Hakan +5 more
doaj +1 more source
Canadian Journal of Infectious Diseases and Medical Microbiology, 2009 BACKGROUND: In 2008, ceftobiprole was approved by Health Canada for the treatment of patients with complicated skin and skin structure infections including diabetic foot infections; approval of ceftobiprole by the United States Food and Drug ...
James A Karlowsky +3 more
doaj +1 more source
مجلة علوم ذي قارSurgical site infection (SSI) is a major source of morbidity and mortality in developing countries despite recent advances in sterile techniques. We studied antibiotics through their effect on bacterial pathogens isolated from wound infections singly ...
Ali Qasim, Hind Abdullah Salih
doaj +1 more source
, 2017 BACKGROUND: Acinetobacter baumannii infections are difficult to treat owing to the emergence of various antibiotic resistant isolates. Because treatment options are limited for multidrug-resistant (MDR) A.
정석훈
core +1 more source
Doripenem (Doribax): The Newest Addition to the Carbapenems [PDF]
Baylor University Medical Center Proceedings, 2008 Carbapenems are a class of antimicrobials structurally related to penicillin. Doripenem, the newest agent in this class, was recently approved by the Food and Drug Administration for the treatment of complicated intra-abdominal infections and complicated urinary tract infections.
openaire +2 more sources
Фармакоэкономика, 2015 the article presents the results of a retrospective study conducted in the period from 2008 to 2011 in Moscow’s hospitals. The aim of the study was to compare the clinical and pharmacoeconomical efficacy of carbapenems in nosocomial pneumonia treatment ...
I. I. Shteynberg +2 more
doaj